Kenjiro Namikawa

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 59

Top Topics

Prognostic Factors

Basal Cell Carcinoma

Top Venues

The Journal of dermatology

International journal of dermatology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Seiji Tsuruta, Dai Ogata, Kenjiro Namikawa, Eiji Nakano, Naoya Yamazaki
A review of cutaneous apocrine carcinoma: epidemiology, diagnosis, prognosis, and treatment options. Japanese journal of clinical oncology (2024)
Naohito Hatta, Dai Ogata, Jun Asai, Takeo Maekawa, Takamichi Ito, Tatsuya Takenouchi, Yukiko Kiniwa, Azusa Miyashita, Takuya Miyagawa, Ikko Muto, Yuki Yamamoto, Tohru Nagano, Yoshio Kiyohara, Eiji Nakano, Shuichi Ohe, Buntaro Yamaguchi, Masahiro Fukuyama, Taisuke Matsuya, Arata Tsutsumida, Kenjiro Namikawa, Naoya Yamazaki
Recent treatment and prognosis in 643 patients with extramammary Paget's disease. Experimental dermatology 33 (2) (2024)
Kenjiro Namikawa, Eiji Nakano, Dai Ogata, Naoya Yamazaki
Long-term survival with systemic therapy in the last decade: Can melanoma be cured? The Journal of dermatology (2024)
Eiji Nakano, Akira Takahashi, Dai Ogata, Kenjiro Namikawa, Naoya Yamazaki
Real-world efficacy and safety of BRAF-targeted therapy for patients with advanced melanoma: A single-center retrospective study in Japan. The Journal of dermatology (2024)
Naohito Hatta, Dai Ogata, Jun Asai, Takeo Maekawa, Takamichi Ito, Tatsuya Takenouchi, Yukiko Kiniwa, Azusa Miyashita, Takuya Miyagawa, Ikko Muto, Yuki Yamamoto, Tohru Nagano, Yoshio Kiyohara, Eiji Nakano, Shuichi Ohe, Buntaro Yamaguchi, Masahiro Fukuyama, Taisuke Matsuya, Arata Tsutsumida, Kenjiro Namikawa, Naoya Yamazaki
Recent treatment and prognosis in 643 patients with extramammary Paget's disease. Experimental dermatology 33 (2) (2024)
Shogo Wada, Eiji Nakano, Miho Nakajima, Satsuki Kishikawa, Akihiko Yoshida, Taisuke Mori, Atsuyoshi Osada, Dai Ogata, Kenjiro Namikawa, Naoya Yamazaki
Congenital dermatofibrosarcoma protuberans on the scalp enlarging and shrinking repeatedly. The Journal of dermatology (2024)
Yusuke Muto, Taku Fujimura, Akira Takahashi, Kenjiro Namikawa, Dai Ogata, Eiji Nakano, Shunichi Jinnai, Akira Hashimoto, Yumi Kanbayashi, Yoshihide Asano, Naoya Yamazaki
Analysis of surgical margins and prognostic factors in dermatofibrosarcoma protuberans after wide local excision: A multicenter study of 116 Japanese patients. The Journal of dermatology 51 (9) (2024)
Kenjiro Namikawa, Eiji Nakano, Dai Ogata, Naoya Yamazaki
Long-term survival with systemic therapy in the last decade: Can melanoma be cured? The Journal of dermatology 51 (3) (2024)
Yusuke Muto, Taku Fujimura, Akira Takahashi, Kenjiro Namikawa, Dai Ogata, Eiji Nakano, Shunichi Jinnai, Akira Hashimoto, Yumi Kanbayashi, Yoshihide Asano, Naoya Yamazaki
Analysis of surgical margins and prognostic factors in dermatofibrosarcoma protuberans after wide local excision: A multicenter study of 116 Japanese patients. The Journal of dermatology (2024)
Eiji Nakano, Akira Takahashi, Dai Ogata, Kenjiro Namikawa, Naoya Yamazaki
Real-world efficacy and safety of BRAF-targeted therapy for patients with advanced melanoma: A single-center retrospective study in Japan. The Journal of dermatology 51 (9) (2024)
Shogo Wada, Eiji Nakano, Miho Nakajima, Satsuki Kishikawa, Akihiko Yoshida, Taisuke Mori, Atsuyoshi Osada, Dai Ogata, Kenjiro Namikawa, Naoya Yamazaki
Congenital dermatofibrosarcoma protuberans on the scalp enlarging and shrinking repeatedly. The Journal of dermatology 51 (6) (2024)
Kenjiro Namikawa, Eiji Nakano, Dai Ogata, Naoya Yamazaki
Long-term survival with systemic therapy in the last decade: Can melanoma be cured? The Journal of dermatology 51 (3) (2024)
Dai Ogata, Kenjiro Namikawa, Eiji Nakano, Maiko Fujimori, Yosuke Uchitomi, Takahiro Higashi, Naoya Yamazaki, Akira Kawai
Epidemiology of skin cancer based on Japan's National Cancer Registry 2016-2017. Cancer science (2023)
Shogo Wada, Dai Ogata, Eiji Nakano, Kenjiro Namikawa, Naoya Yamazaki
Efficacy of chemotherapies for unresectable extramammary Paget disease: a single-centre retrospective study. Clinical and experimental dermatology (2023)
Eiji Nakano, Dai Ogata, Kenjiro Namikawa, Naoya Yamazaki
Merkel cell carcinoma: a review of clinical management with focus on Asian patients. Japanese journal of clinical oncology (2023)
Go Omura, Kenjiro Namikawa, Toshihiko Sakai, Kohtaro Eguchi, Yoshifumi Matsumoto, Azusa Sakai, Kenya Kobayashi, Eiji Nakano, Dai Ogata, Fumihiko Matsumoto, Taisuke Mori, Naoya Yamazaki, Seiichi Yoshimoto
Clinical outcomes of head and neck mucosal melanoma treated with surgery: a single-center study in Japan. Japanese journal of clinical oncology (2023)
Yasuhiro Fujisawa, Kenjiro Namikawa, Koji Yoshino, Yukiko Kiniwa, Takamichi Ito, Hiroshi Kato, Shigeto Matsushita, Toshihiko Hoashi, Yasuhiro Nakamura, Shusuke Yoshikawa, Takuya Miyagawa, Jun Asai, Taisuke Matsuya, Satoshi Fukushima, Jyunji Kato, Tatsuya Takenouchi, Hiroshi Uchi, Mamiko Masuzawa, Teruki Yanagi, Takeo Maekawa
Combined use of nivolumab and ipilimumab among Japanese melanoma patients: Multi-center, retrospective study of 111 cases. The British journal of dermatology (2023)
Kenjiro Namikawa, Takamichi Ito, Shusuke Yoshikawa, Koji Yoshino, Yukiko Kiniwa, Shuichi Ohe, Taiki Isei, Tatsuya Takenouchi, Hiroshi Kato, Satoru Mizuhashi, Satoshi Fukushima, Yosuke Yamamoto, Takashi Inozume, Yasuhiro Fujisawa, Osamu Yamasaki, Yasuhiro Nakamura, Jun Asai, Takeo Maekawa, Takeru Funakoshi, Shigeto Matsushita, Eiji Nakano, Kohei Oashi, Junji Kato, Hisashi Uhara, Takuya Miyagawa, Hiroshi Uchi, Naohito Hatta, Keita Tsutsui, Taku Maeda, Taisuke Matsuya, Hiroto Yanagisawa, Ikko Muto, Mao Okumura, Dai Ogata, Naoya Yamazaki
Systemic therapy for Asian patients with advanced BRAF V600-mutant melanoma in a real-world setting: A multi-center retrospective study in Japan (B-CHECK-RWD study). Cancer medicine (2023)
Shogo Wada, Tomone Watanabe, Taisuke Ishii, Yuichi Ichinose, Ryoko Rikitake, Dai Ogata, Eiji Nakano, Kenjiro Namikawa, Naoya Yamazaki, Takahiro Higashi
A retrospective study of sentinel lymph node biopsy for skin cancer in Japan: Comparison with breast cancer and evaluation of factors related to its use. Cancer medicine (2023)
Dai Ogata, Kenjiro Namikawa, Eiji Nakano, Maiko Fujimori, Yosuke Uchitomi, Takahiro Higashi, Naoya Yamazaki, Akira Kawai
Epidemiology of skin cancer based on Japan's National Cancer Registry 2016-2017. Cancer science (2023)
Dai Ogata, Kenjiro Namikawa, Eiji Nakano, Maiko Fujimori, Yosuke Uchitomi, Takahiro Higashi, Naoya Yamazaki, Akira Kawai
Epidemiology of skin cancer based on Japan's National Cancer Registry 2016-2017. Cancer science (2023)
Yuichi Nakayama, Dai Ogata, Shogo Wada, Seiji Tsuruta, Yoshiyuki Matsui, Mao Okumura, Kojiro Hiki, Eiji Nakano, Kenjiro Namikawa, Naoya Yamazaki
Treatment of high tumor mutation burden metastatic extramammary Paget disease with an anti-PD-1 antibody. The Journal of dermatology (2023)
Shogo Wada, Dai Ogata, Tairo Kashihara, Kae Okuma, Hirofumi Eto, Eiji Nakano, Akira Takahashi, Kenjiro Namikawa, Hiroshi Igaki, Naoya Yamazaki
A single-center retrospective analysis of prognoses in patients with melanoma brain metastases and effectiveness of treatment in Japan. Cancer medicine (2023)
Mao Okumura, Dai Ogata, Kenjiro Namikawa, Akira Takahashi, Masashi Akiyama, Naoya Yamazaki
Functional preservation benefits of minimal surgery for extramammary Paget's disease. Experimental dermatology (2023)
Mao Okumura, Dai Ogata, Kenjiro Namikawa, Keita Tsutsui, Akira Takahashi, Kae Okuma, Tairo Kashihara, Hiroshi Igaki, Masashi Akiyama, Naoya Yamazaki
Postoperative radiation therapy improves prognoses in extramammary Paget's disease presenting with multiple lymph node metastases. The Journal of dermatology 49 (10) (2022)
Naoya Yamazaki, Taiki Isei, Yoshio Kiyohara, Hiroshi Koga, Takashi Kojima, Tatsuya Takenouchi, Kenji Yokota, Kenjiro Namikawa, Min Yi, Alissa Keegan, Satoshi Fukushima
A phase I study of the safety and efficacy of talimogene laherparepvec in Japanese patients with advanced melanoma. Cancer science 113 (8) (2022)
Anna Kamimura, Yasuhiro Nakamura, Tatsuya Takenouchi, Shigeto Matsushita, Toshikazu Omodaka, Kentaro Yamamura, Hiroshi Uchi, Shusuke Yoshikawa, Hiroto Yanagisawa, Takamichi Ito, Yoshio Kiyohara, Yoshio Nakamura, Megumi Aoki, Shoichiro Ishizuki, Kohei Oashi, Takuya Miyagawa, Taku Maeda, Dai Ogata, Naohito Hatta, Shuichi Ohe, Taiki Isei, Akira Takahashi, Yoshiyasu Umeda, Buntaro Yamaguchi, Masashi Ishikawa, Kohei Horimoto, Yasuhiro Fujisawa, Jiro Uehara, Yoshitsugu Shibayama, Yukiko Kiniwa, Yu Kawahara, Taisuke Matsuya, Hisashi Uhara, Junji Kato, Yoshiyuki Nakamura, Takuo Murakami, Kenjiro Namikawa, Koji Yoshino, Takeru Funakoshi, Sumiko Takatsuka, Yu Matsui, Jin Sasaki, Hiroshi Koga, Kenji Yokota, Takaya Komori, Satoshi Fukushima, Naoya Yamazaki
Concordance in judgment of clinical borders of basal cell carcinomas in Japanese patients: A preliminary study of JCOG2005 (J-BASE-MARGIN). The Journal of dermatology 49 (9) (2022)
Kohei Yamakawa, Dai Ogata, Kojiro Hiki, Shunichi Jinnai, Kenjiro Namikawa, Akira Takahashi, Naoya Yamazaki
Metastatic basal cell carcinoma with a high tumor mutational burden that achieved complete response with pembrolizumab. International journal of dermatology (2022)
Junji Kato, Kenjiro Namikawa, Jiro Uehara, Motoo Nomura, Yasuhiro Nakamura, Hisashi Uhara, Hiroshi Uchi, Shusuke Yoshikawa, Yukiko Kiniwa, Yoshiyuki Nakamura, Takuya Miyagawa, Shigeto Matsushita, Tatsuya Takenouchi, Naohito Hatta, Fumitaka Ohno, Taku Maeda, Satoshi Fukushima, Naoya Yamazaki
Prognoses of patients with melanoma who continue/discontinue anti-programmed death-1 therapy after achieving a complete response in a real-world setting: a multicentre retrospective study. The British journal of dermatology 187 (4) (2022)
Tairo Kashihara, Dai Ogata, Kae Okuma, Satoshi Nakamura, Hiroki Nakayama, Taisuke Mori, Akira Takahashi, Kenjiro Namikawa, Ayaka Takahashi, Kana Takahashi, Tomoya Kaneda, Koji Inaba, Naoya Murakami, Hiroyuki Okamoto, Yuko Nakayama, Naoya Yamazaki, Hiroshi Igaki
Clinical significance of local control of primary tumour in definitive radiotherapy for scalp angiosarcomas. Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) (2022)
Akira Takahashi, Kenjiro Namikawa, Dai Ogata, Shunichi Jinnai, Eiji Nakano, Naoya Yamazaki
Updated analysis of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma. The Journal of dermatology (2022)
Kojiro Hiki, Dai Ogata, Izumi Hisada, Taku Sakamoto, Takamaru Hiroyuki, Kohei Yamakawa, Kenjiro Namikawa, Akira Takahashi, Yutaka Saito, Naoya Yamazaki
Minimally invasive surgery combined with excision and endoscopic submucosal dissection for anorectal melanoma. The Journal of dermatology (2022)
Akihiro Ishiguro, Dai Ogata, Kae Okuma, Tairo Kashihara, Naoya Murakami, Kojiro Hiki, Kohei Yamakawa, Shunichi Jinnai, Akira Takahashi, Kenjiro Namikawa, Hiroshi Igaki, Naoya Yamazaki
Malignant melanoma treatment using brachytherapy: Two case reports and 15 case series. The Journal of dermatology (2022)
Shunichi Jinnai, Kenjiro Namikawa, Akira Takahashi, Dai Ogata, Naoya Yamazaki
Incidence and patterns of lymphatic drainage to the epitrochlear and popliteal sentinel lymph nodes in malignant melanoma of the distal extremities: a single-institution retrospective study. International journal of dermatology 61 (7) (2022)
Mao Okumura, Eiji Nakano, Kenjiro Namikawa, Akira Takahashi, Yutaka Fujiwara, Naoya Yamazaki
Efficacy of surgery for skin cancers initially suspected to be carcinoma of unknown primary: a retrospective observational study. International journal of dermatology (2021)
Akihiro Ishiguro, Dai Ogata, Kenjiro Namikawa, Akira Takahashi, Naoya Yamazaki
Two cases of advanced cutaneous squamous cell carcinoma lesions on the head and neck successfully treated with nivolumab. The Journal of dermatology 48 (9) (2021)
Keita Tsutsui, Katsuko Kikuchi, Keiko Nozawa, Atsuo Takashima, Kenichiro Tsuchiyama, Kenjiro Namikawa, Setsuya Aiba, Naoya Yamazaki
Efficacy and safety of topical benzoyl peroxide for prolonged acneiform eruptions induced by cetuximab and panitumumab: A multicenter, phase II trial. The Journal of dermatology 48 (7) (2021)
Erina Takai, Wataru Omata, Yasushi Totoki, Hiromi Nakamura, Satoshi Shiba, Akira Takahashi, Kenjiro Namikawa, Taisuke Mori, Naoya Yamazaki, Tatsuhiro Shibata, Hirotsugu Shiroma
Clonal dynamics of circulating tumor DNA during immune checkpoint blockade therapy for melanoma. Cancer science 112 (11) (2021)
Kenta Nakama, Dai Ogata, Eiji Nakano, Keita Tsutsui, Shunichi Jinnai, Kenjiro Namikawa, Akira Takahashi, Naoya Yamazaki
Clinical response to a MEK inhibitor in a patient with metastatic melanoma harboring an RAF1 gene rearrangement detected by cancer gene panel testing. The Journal of dermatology 48 (6) (2021)
Akira Takahashi, Kenjiro Namikawa, Dai Ogata, Eiji Nakano, Shunichi Jinnai, Kenta Nakama, Keita Tsutsui, Yusuke Muto, Haruki Mizuta, Naoya Yamazaki
Real-world efficacy and safety data of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma. The Journal of dermatology 47 (11) (2020)
Keita Tsutsui, Akira Takahashi, Taisuke Mori, Kenjiro Namikawa, Naoya Yamazaki
Secretory carcinoma of the skin arising on the eyelid, distinguished by immunohistochemical markers and fluorescence in situ hybridization. The Journal of dermatology 47 (3) (2020)
Haruki Mizuta, Akira Takahashi, Kenjiro Namikawa, Dai Ogata, Naoya Yamazaki
Association between prognosis and complete resection in primary cutaneous myoepithelial carcinoma: two case presentations and literature review. Dermatologic therapy 33 (4) (2020)
Eiji Nakano, Akira Takahashi, Kenjiro Namikawa, Yusuke Muto, Shunichi Jinnai, Yuta Kage, Haruki Mizuta, Arata Tsutsumida, Naoya Yamazaki
Correlation between cutaneous adverse events and prognosis in patients with melanoma treated with nivolumab: A single institutional retrospective study. The Journal of dermatology 47 (6) (2020)
Kenjiro Namikawa, Yoshio Kiyohara, Tatsuya Takenouchi, Hisashi Uhara, Hiroshi Uchi, Shusuke Yoshikawa, Sumiko Takatsuka, Hiroshi Koga, Naoko Wada, Hironobu Minami, Masahiro Hatsumichi, Yoshinobu Namba, Naoya Yamazaki
Final analysis of a phase II study of nivolumab in combination with ipilimumab for unresectable chemotherapy-naive advanced melanoma. The Journal of dermatology 47 (11) (2020)
Haruki Mizuta, Kenjiro Namikawa, Akira Takahashi, Dai Ogata, Yusuke Muto, Shunichi Jinnai, Kenta Nakama, Keita Tsutsui, Naoya Yamazaki
The first case of a collision tumor of melanotrichoblastoma and seborrheic keratosis. International journal of dermatology 60 (2) (2020)
Haider A Mejbel, Carlos A Torres-Cabala, Denái R Milton, Doina Ivan, Laurence Feldmeyer, Kenjiro Namikawa, Priyardhisini Nagarajan, Michael T Tetzlaff, Jonathan L Curry, Merrick I Ross, Wen-Jen Hwu, Victor G Prieto, Leomar Y Ballester
Prognostic significance of acral lentiginous histologic type in T1 melanoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 34 (3) (2020)
Haruki Mizuta, Eiji Nakano, Akira Takahashi, Takafumi Koyama, Kenjiro Namikawa, Naoya Yamazaki
Hemophagocytic lymphohistiocytosis with advanced malignant melanoma accompanied by ipilimumab and nivolumab: A case report and literature review. Dermatologic therapy 33 (3) (2020)
Haruki Mizuta, Akira Takahashi, Taisuke Mori, Kenjiro Namikawa, Eiji Nakano, Yusuke Muto, Shunichi Jinnai, Kenta Nakama, Keita Tsutsui, Naoya Yamazaki
Efficacy of oral retinoids for keratoacanthoma centrifugum marginatum. Dermatologic therapy 33 (3) (2020)
Keita Tsutsui, Kenjiro Namikawa, Taisuke Mori, Ken Kato, Shunichi Jinnai, Kenta Nakama, Dai Ogata, Akira Takahashi, Naoya Yamazaki
Case of acquired reactive perforating collagenosis induced by panitumumab for colon cancer. The Journal of dermatology 48 (2) (2020)
Keita Tsutsui, Akira Takahashi, Yusuke Muto, Haruki Mizuta, Shunichi Jinnai, Kenta Nakama, Dai Ogata, Kenjiro Namikawa, Naoya Yamazaki
Outcomes of lymph node dissection in the treatment of extramammary Paget's disease: A single-institution study. The Journal of dermatology 47 (5) (2020)
Keita Tsutsui, Kenjiro Namikawa, Taisuke Mori, Shunichi Jinnai, Kenta Nakama, Dai Ogata, Akira Takahashi, Naoya Yamazaki
Case of multiple ectopic extramammary Paget's disease of the trunk. The Journal of dermatology 47 (9) (2020)
Keita Tsutsui, Kenjiro Namikawa, Akira Takahashi, Naoya Yamazaki
Reconstruction with scrotal flap for extramammary Paget's disease of the groin, penis, and scrotum: a single-institution case series. International journal of dermatology 59 (3) (2019)
Yasuhiro Nakamura, Jun Asai, Hiroshi Igaki, Takashi Inozume, Kenjiro Namikawa, Ayato Hayashi, Satoshi Fukushima, Taku Fujimura, Takamichi Ito, Keisuke Imafuku, Ryota Tanaka, Yukiko Teramoto, Akane Minagawa, Takuya Miyagawa, Azusa Miyashita, Makoto Wada, Hiroshi Koga, Makoto Sugaya
Japanese Dermatological Association Guidelines: Outlines of guidelines for cutaneous melanoma 2019. The Journal of dermatology 47 (2) (2019)
Kenjiro Namikawa, Phyu P Aung, Denái R Milton, Michael T Tetzlaff, Carlos A Torres-Cabala, Jonathan L Curry, Priyardhisini Nagarajan, Doina Ivan, Merrick Ross, Jeffrey E Gershenwald, Victor G Prieto
Correlation of Tumor Burden in Sentinel Lymph Nodes with Tumor Burden in Nonsentinel Lymph Nodes and Survival in Cutaneous Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (24) (2019)
Akira Takahashi, Kenjiro Namikawa, Eiji Nakano, Naoya Yamazaki
Real-world efficacy and safety data for dabrafenib and trametinib combination therapy in Japanese patients with BRAF V600 mutation-positive advanced melanoma. The Journal of dermatology 47 (3) (2019)
Yusuke Muto, Kenjiro Namikawa, Yutaka Fujiwara, Taisuke Mori, Eiji Nakano, Akira Takahashi, Naoya Yamazaki
Bullous pemphigoid induced by pembrolizumab in a patient with non-small-cell lung cancer who achieved durable complete response despite treatment cessation and long-term corticosteroid administration: A case report. The Journal of dermatology 47 (1) (2019)
Yasuhiro Fujisawa, Shusuke Yoshikawa, Akane Minagawa, Tatsuya Takenouchi, Kenji Yokota, Hiroshi Uchi, Naoki Noma, Yasuhiro Nakamura, Jun Asai, Junji Kato, Susumu Fujiwara, Satoshi Fukushima, Jiro Uehara, Toshihiko Hoashi, Tatsuya Kaji, Taku Fujimura, Kenjiro Namikawa, Manabu Yoshioka, Naoki Murao, Dai Ogata, Kanako Matsuyama, Naohito Hatta, Yoshitsugu Shibayama, Toshiharu Fujiyama, Masashi Ishikawa, Daisuke Yamada, Akiko Kishi, Yoshiyuki Nakamura, Takatoshi Shimiauchi, Kazuyasu Fujii, Manabu Fujimoto, Hironobu Ihn, Norito Katoh
Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma. Cancer medicine 8 (5) (2019)
Kenjiro Namikawa, Leomar Y Ballester, Jeffrey E Gershenwald, Denái R Milton, Victor G Prieto
Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center. Cancer medicine 7 (3) (2018)
Yoshitsugu Shibayama, Kenjiro Namikawa, Miyuki Sone, Akira Takahashi, Arata Tsutsumida, Shunsuke Sugawara, Yasuaki Arai, Yukiko Aihara, Shigenobu Suzuki, Juichiro Nakayama, Shinichi Imafuku, Naoya Yamazaki
Efficacy and toxicity of transarterial chemoembolization therapy using cisplatin and gelatin sponge in patients with liver metastases from uveal melanoma in an Asian population. International journal of clinical oncology 22 (3) (2017)